Faster and more precise
Current dementia testing methods are costly, inaccessible to many and mostly used for late-stage diagnosis. Our technology generates ‘optical fingerprints’ from blood samples that are unique to different types of dementia and enable accurate identification of dementia, earlier and faster.
Mission
Our mission is to revolutionize dementia detection through a low-cost, 5-minute AI-powered blood test that detects and distinguishes multiple forms of dementia early to enable better treatment and care
Vision
Our vision is to democratise dementia diagnosis on a global scale and pioneer the first global dementia screening program using our DementiaDX technology
Proven, simple, and scalable
Refined through NHS trials, our MX-Raman® technology is protected with patents pending in the USA, UK and EU and set to transform how healthcare systems diagnose and treat dementia at scale.
Faster and more precise
Current dementia testing methods are costly, inaccessible to many and mostly used for late-stage diagnosis. Our technology generates ‘optical fingerprints’ from blood samples that are unique to different types of dementia and enable accurate identification of dementia, earlier and faster.